Clinical Trials for Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements

Find clinical trials for recurrent high grade b-cell lymphoma with myc, bcl2, and bcl6 rearrangements. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

NCT ID: NCT06649812

This clinical trial, called ViPOR, is exploring a new combination of treatments for patients with aggressive types of B-cell lymphoma that have either come back after treatment (relapsed) or have n...

Not yet recruiting

Phase: PHASE2 Type: interventional

Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

NCT ID: NCT06536049

This clinical trial is studying a new treatment option for patients with aggressive types of B-cell non-Hodgkin lymphoma that have either come back after previous treatments or did not respond to t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Minneapolis, Minnesota, United States, Columbus, Ohio, United States

TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT ID: NCT05507541

This clinical trial is exploring a new treatment option for patients with a type of blood cancer called diffuse large B-cell lymphoma, which has either returned after treatment or has not responded...

Recruiting

Phase: PHASE2 Type: interventional Locations: Rochester, Minnesota, United States, Iowa City, Iowa, United States +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions